Foundations Investment Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$707K Sell
2,415
-428
-15% -$141K 0.01% 617
2025
Q4
$997K Buy
2,843
+159
+6% +$53.7K 0.01% 514
2025
Q3
$867K Sell
2,684
-815
-23% -$253K 0.01% 501
2025
Q2
$1.36M Sell
3,499
-608
-15% -$245K 0.02% 366
2025
Q1
$1.79M Sell
4,107
-1,069
-21% -$429K 0.03% 306
2024
Q4
$1.91M Sell
5,176
-23,961
-82% -$10M 0.04% 297
2024
Q3
$15.2M Buy
29,137
+3,893
+15% +$2.08M 0.32% 74
2024
Q2
$13.7M Buy
25,244
+5,588
+28% +$2.95M 0.33% 69
2024
Q1
$10.2M Buy
19,656
+3,380
+21% +$1.68M 0.27% 75
2023
Q4
$8.06M Buy
16,276
+5,166
+46% +$2.39M 0.22% 91
2023
Q3
$4.84M Buy
11,110
+4,072
+58% +$1.85M 0.15% 114
2023
Q2
$3.13M Buy
7,038
+3,049
+76% +$1.41M 0.1% 141
2023
Q1
$1.83M Buy
3,989
+1,116
+39% +$531K 0.07% 181
2022
Q4
$1.47M Sell
2,873
-2,296
-44% -$1.17M 0.06% 164
2022
Q3
$2.35M Sell
5,169
-1,580
-23% -$756K 0.1% 87
2022
Q2
$3.27M Sell
6,749
-369
-5% -$183K 0.14% 74
2022
Q1
$3.68M Buy
7,118
+352
+5% +$161K 0.14% 58
2021
Q4
$3.06M Buy
6,766
+793
+13% +$334K 0.12% 71
2021
Q3
$2.23M Buy
5,973
+608
+11% +$231K 0.1% 79
2021
Q2
$2.08M Buy
5,365
+1,126
+27% +$430K 0.1% 74
2021
Q1
$1.49M Buy
4,239
+719
+20% +$231K 0.09% 74
2020
Q4
$1.19M Buy
3,520
+310
+10% +$95.1K 0.08% 70
2020
Q3
$883K Buy
3,210
+332
+12% +$89.3K 0.19% 80
2020
Q2
$768K Buy
2,878
+477
+20% +$127K 0.07% 89
2020
Q1
$514K Buy
2,401
+273
+13% +$74.4K 0.06% 69
2019
Q4
$639K Sell
2,128
-159
-7% -$43.8K 0.08% 82
2019
Q3
$545K Buy
2,287
+425
+23% +$116K 0.07% 86
2019
Q2
$527K Buy
1,862
+1,052
+130% +$287K 0.08% 81
2019
Q1
$232K Buy
810
+50
+7% +$14.5K 0.04% 87
2018
Q4
$231K Sell
760
-46
-6% -$12.6K 0.05% 90
2018
Q3
$221K Buy
+806
New +$209K 0.05% 93

Other funds holding ELV

Foundations Investment Advisors's ELV Position: Q1 2026 in Review

Foundations Investment Advisors reduced its Elevance Health (ELV) stake by 15% in Q1 2026, selling an estimated $141K and leaving 2,415 shares worth $707K. The position accounts for 0.01% of the portfolio, ranked #617.

Foundations Investment Advisors first reported a position in ELV in Q3 2018 and has held it in 31 quarters since. The position peaked at $15.2M in Q3 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Foundations Investment Advisors held 2,415 shares of Elevance Health worth $707K as of Q1 2026.
  • Foundations Investment Advisors sold 428 Elevance Health shares in Q1 2026, an estimated $141K.
  • Elevance Health made up 0.01% of Foundations Investment Advisors's portfolio in Q1 2026, its #617 holding.
  • Foundations Investment Advisors first reported a position in Elevance Health in Q3 2018 and has held it in 31 quarters since.
  • Foundations Investment Advisors's Elevance Health position peaked at $15.2M in Q3 2024.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Foundations Investment Advisors's 13F filing for Q1 2026, filed 11 May 2026.